no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?
|
Chen, Yuehong |
|
2018 |
101 |
C |
p. 78-88 |
article |
2 |
Editorial board
|
|
|
2018 |
101 |
C |
p. i |
article |
3 |
How much have we learnt about the TNF family of cytokines?
|
Chu, Cong-Qiu |
|
2018 |
101 |
C |
p. 1-3 |
article |
4 |
Intracellular regulation of TNF activity in health and disease
|
Varfolomeev, Eugene |
|
2018 |
101 |
C |
p. 26-32 |
article |
5 |
Lymphotoxin in physiology of lymphoid tissues – Implication for antiviral defense
|
Koroleva, Ekaterina P. |
|
2018 |
101 |
C |
p. 39-47 |
article |
6 |
Making anti-cytokine therapy more selective: Studies in mice
|
Drutskaya, Marina S. |
|
2018 |
101 |
C |
p. 33-38 |
article |
7 |
Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists
|
Mitoma, Hiroki |
|
2018 |
101 |
C |
p. 56-63 |
article |
8 |
Molecular probing of TNF: From identification of therapeutic target to guidance of therapy in inflammatory diseases
|
Chu, Cong-Qiu |
|
2018 |
101 |
C |
p. 64-69 |
article |
9 |
Progranulin: A key player in autoimmune diseases
|
Jian, Jinlong |
|
2018 |
101 |
C |
p. 48-55 |
article |
10 |
Reprint of “Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab”
|
Cludts, Isabelle |
|
2018 |
101 |
C |
p. 70-77 |
article |
11 |
TNF activity and T cells
|
Mehta, Amit K. |
|
2018 |
101 |
C |
p. 14-18 |
article |
12 |
TNF-α and IGF-1 differentially modulate ionizing radiation responses of lung cancer cell lines
|
Pal, Shyama |
|
2018 |
101 |
C |
p. 89-98 |
article |
13 |
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
|
Bystrom, Jonas |
|
2018 |
101 |
C |
p. 4-13 |
article |
14 |
TNFR signalling and its clinical implications
|
Tseng, Wen-Yi |
|
2018 |
101 |
C |
p. 19-25 |
article |